U of M Launches Startup Developing Bioengineered Tissue That Could Shake Up Medical Device Market
A recently launched U of M startup is developing tissue for medical device and therapeutics applications.
Based in Stillwater, Vascudyne is dedicated to developing a special type of tissue made from skin cells. Preclinical studies suggest the biologically engineered tissue is capable of healing itself and even growing with the patient since it shares properties similar to the tissue in a human body.
Vascudyne is advertising its technology as having regenerative capabilities unmatched in the market today. The new tissue has the potential to transform the medical device and therapeutics markets, the U of M said, which are both being hampered by synthetic tissues that are limited by their supply, durability, and hemocompatibility constraints.
The full story was published in December, 2018, in Twin Cities Business.